The repeated message of delivering a better than 90% healing rate has convinced payers that advanced therapeutics are overutilized, or at least not worth the price tag. The fine print is that we heal everyone, “except for the outliers.” The...
The repeated message of delivering a better than 90% healing rate has convinced payers that advanced therapeutics are overutilized, or at least not worth the price tag. The fine print is that we heal everyone, “except for the outliers.” The...
The repeated message of...